Acetylation of HIV-1 Tat by CBP/P300 increases transcription of integrated HIV-1 genome and enhances binding to core histones

被引:138
作者
Deng, LW
de la Fuente, C
Fu, P
Wang, L
Donnelly, R
Wade, JD
Lambert, P
Li, H
Lee, CG
Kashanchi, F
机构
[1] Univ Med & Dent New Jersey, New Jersey Med Sch, Dept Biochem & Mol Biol, Newark, NJ 07103 USA
[2] Univ Med & Dent New Jersey, New Jersey Med Sch, Dept Pathol, Newark, NJ 07103 USA
[3] Univ Melbourne, Howard Florey Inst, Parkville, Vic 3052, Australia
[4] Flinders Univ S Australia, Sch Med, Bedford Pk, SA 5042, Australia
关键词
D O I
10.1006/viro.2000.0593
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
The HIV-1 Tat protein is required for viral replication and is a potent stimulator of viral transcription. Although Tat has been extensively studied in various reductive paradigms, to date there is little information as to how this activator mediates transcription from natural nucleosomally packaged long terminal repeats. Here we show that CREB-binding protein (CBP)/ p300 interacts with the HIV-1 Tat protein and serves as a coactivator of Tat-dependent HIV-1 gene expression on an integrated HIV-1 provirus. The site of acetylation of Tat was mapped to the double-lysine motif in a highly conserved region, (49)RKKRRQ(54) Of th, basic RNA-binding motif of Tat. Using HLM1 cells (HIV-1(+)/Tat(-)), which contain a single copy of full-length HIV-1 provirus with a triple termination codon at the first AUG of the Tat gene, we find that only wild type, and not K50A, K51A, or K50A/K51A alone or in combination of ectopic CBP/p300, is able to produce full-length infectious virions, as measured by p24 gag ELISAs. Tat binds CBP/p300 in the minimal histone acetyltransferase domain (1253-1710) and the binding is stable up to 0.85 M salt wash conditions. Interestingly, wild-type peptide 41-54, and not other Tat peptides, changes the conformation of the CBP/p300 such that it can acquire and bind better to basal factors such as TBP and TFIIB, indicating that Tat may influence the transcription machinery by helping CBP/p300 to recruit new partners into the transcription machinery. Finally, using biotinylated wild-type or acetylated peptides, we find that acetylation decreases Tat's ability to bind the TAR RNA element, as well as to bind basal factors such as TBP, CBP, Core-Pol II, or cyclin T However, the acetylated Tat peptide is able to bind to core histones on a nucleosome assembled HIV-1 proviral DNA. (C) 2000 Academic Press.
引用
收藏
页码:278 / 295
页数:18
相关论文
共 75 条
[1]   CELLULAR LATENCY IN HUMAN IMMUNODEFICIENCY VIRUS-INFECTED INDIVIDUALS WITH HIGH CD4 LEVELS CAN BE DETECTED BY THE PRESENCE OF PROMOTER-PROXIMAL TRANSCRIPTS [J].
ADAMS, M ;
SHARMEEN, L ;
KIMPTON, J ;
ROMEO, JM ;
GARCIA, JV ;
PETERLIN, BM ;
GROUDINE, M ;
EMERMAN, M .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1994, 91 (09) :3862-3866
[2]   Histone acetyltransferase activity of CBP is controlled by cycle-dependent kinases and oncoprotein E1A [J].
Ait-Si-Ali, S ;
Ramirez, S ;
Barre, FX ;
Dkhissi, F ;
Magnaghi-Jaulin, L ;
Girault, JA ;
Robin, P ;
Knibiehler, M ;
Pritchard, LL ;
Ducommun, B ;
Trouche, D ;
Harel-Bellan, A .
NATURE, 1998, 396 (6707) :184-186
[3]   The CBP co-activator is a histone acetyltransferase [J].
Bannister, AJ ;
Kouzarides, T .
NATURE, 1996, 384 (6610) :641-643
[4]   Activation of integrated provirus requires histone acetyltransferase - p300 AND P/CAF are coactivators for HIV-1 Tat [J].
Benkirane, M ;
Chun, RF ;
Xiao, H ;
Ogryzko, VV ;
Howard, BH ;
Nakatani, Y ;
Jeang, KT .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1998, 273 (38) :24898-24905
[5]   Recruitment of cyclin T1/P-TEFb to an HIV type I long terminal repeat promoter proximal RNA target is both necessary and sufficient for full activation of transcription [J].
Bieniasz, PD ;
Grdina, TA ;
Bogerd, HP ;
Cullen, BR .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1999, 96 (14) :7791-7796
[6]   The histone acetylase PCAF is a nuclear receptor coactivator [J].
Blanco, JCG ;
Minucci, S ;
Lu, JM ;
Yang, XJ ;
Walker, KK ;
Chen, HW ;
Evans, RM ;
Nakatani, Y ;
Ozato, K .
GENES & DEVELOPMENT, 1998, 12 (11) :1638-1651
[7]  
Burysek L, 1999, J VIROL, V73, P7334
[8]   A viral mechanism for inhibition of p300 and PCAF acetyltransferase activity [J].
Chakravarti, D ;
Ogryzko, V ;
Kao, HY ;
Nash, A ;
Chen, HW ;
Nakatani, Y ;
Evans, RM .
CELL, 1999, 96 (03) :393-403
[9]   Nuclear factor I-mediated repression of the mouse mammary tumor virus promoter is abrogated by the coactivators p300/CBP and SRC-1 [J].
Chaudhry, AZ ;
Vitullo, AD ;
Gronostajski, RM .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1999, 274 (11) :7072-7081
[10]  
CHEN D, 1999, P NATL ACAD SCI USA, V6, P2728